# Pillar5 Pharma Inc. – FDA Inspection, Feb 6, 2015

Source: https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/e4104669-72d1-459a-98e2-ca038ce3404e
Source feed: FDA_Inspections

> FDA inspection 917128 of Pillar5 Pharma Inc., February 06, 2015. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 917128
- Company Name: Pillar5 Pharma Inc.
- Inspection Date: 2015-02-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1323174 - 2026-06-05](https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/797a6a97-028e-475d-bd9f-5894cfb5abda)
- [FDA Inspection 1261773 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/9bde498e-2566-4025-8c5b-53bacfb5ac30)
- [FDA Inspection 1226692 - 2023-12-15](https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/d18f4f76-6e8e-4741-826d-9fbbd52772fb)
- FDA Inspection 1119040 - 2020-02-21
- FDA Inspection 1058599 - 2018-05-17

Company: https://www.keypedia.com/companies/pillar5-pharma-inc/8b94b834-f2da-4821-9ddc-6795a5e6d6f0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
